Dynavax Technologies (DVAX) halted ahead of FDA adcom
- China Cuts Benchmark Rate Amid Weaknening Growth Prospects; Markets React (FXI)
- Dow Chemical (DOW), Third Point Enter Agreement; Four New Independent Directors Added
- Large Cut from OPEC Would Be 'Self-Negating', Says Goldman Sachs
- UPDATE: Volkswagen AG (VLKAY) Will Invest EUR 85.6B Over Next 5Y in Auto Ops - Bloomberg
- Technicals Point to $60/Share for Intel (INTC)
Dynavax Technologies Corporation (NASDAQ: DVAX) halted ahead of FDA adcom
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TheStreetSweeper Negative on Blue Nile (NILE)
- Koch Industries to Acquire Oplink Communications (OPLK) for $24.25/Share
- Taser (TASR) Declines on Reports Seattle Police May Scrap Body Camera Plan
Create E-mail Alert Related CategoriesFDA, Trader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!